First and subsequent nonmelanoma skin cancers: Incidence and predictors in a population of New Zealand renal transplant recipients

Nephrology Dialysis Transplantation

Volumn 25, Issue 1, 2010, Pages 300-306

  MacKenzie, Katarzyna A ^a,b   Wells, J Elisabeth ^a   Lynn, Kelvin L ^b   Simcock, Jeremy W ^b   Robinson, Bridget A ^a   Roake, Justin A ^a   Currie, Margaret J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Immunosuppression; Nonmelanoma skin cancer; Renal transplant

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; AGING; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEW ZEALAND; NONMELANOMA SKIN CANCER; POPULATION RESEARCH; PREDICTOR VARIABLE; PRIMARY TUMOR; PRIORITY JOURNAL; SECOND CANCER; SEX RATIO; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

ADULT; AGE FACTORS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEW ZEALAND; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SKIN NEOPLASMS;

EID: 72949109304     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp482     Document Type: Article

References (54)

1. Andres A, Andres A. Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit Rev Oncol Hemato 2005; 56: 71-85
2. Ho W, GM M. Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients. Br J Dermatol 2008; 158: 217-224
3. Bouwes Bavinck J, Hardie D, Green A et al. The risk of skin cancer in renal transplant recipients in queensland, Australia. A follow-up study. Transplantation 1996; 61: 715-721
4. Jensen P, Hansen S, Møller B et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40(Pt 1): 177-186
5. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. The N Engl J Med 2003; 348: 1681-1692
6. Ramsay H, Fryer A, Hawley C et al. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 2002; 147: 950-956
7. Hartevelt MM, Bavinck JN, Kootte A et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49: 506-509
8. Moloney F, Comber H, O'Lorcain P et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154: 498-504
9. Harwood C, Proby C, McGregor J et al. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006; 54: 290-300
10. Penn I. Cancers after cyclosporine therapy. Transplant Proc 1988; 20(Suppl 1): 276-279 (Pubitemid 18111892)
11. Penn I. The changing pattern of posttransplant malignancies. Transplant Proc 1991; 23(Pt 2): 1101-1103
12. Lindelöf B, Sigurgeirsson B, Gäbel H et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143: 513-519
13. Berg D, Otley C. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1-17. http://www.stats.govt.nz/default.htm
14. Primary Prevention Expert Working Group to the Cancer Control Steering Group. Primary prevention. Wellington: Ministry of Health. 2003
15. Health Sponsorship Council. Sunsmart in New Zealand. www.hsc. org.nz
16. Ulrich C, Schmook T, Sachse M et al. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004; 30(Pt 2): 622-627
17. Liddington M, Richardson A, Higgins R et al. Skin cancer in renal transplant recipients. Br J Surg 1989; 76: 1002-1005
18. Carroll R, Ramsay H, Fryer A et al. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia. Am J Kidney Dis 2003; 41: 676-683 (Pubitemid 36278387)
19. Naldi L, Fortina A, Lovati S et al. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 2000; 70: 1479-1484
20. Fuente M, Sabat M, Roca J et al. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol 2003; 149: 1221-1226
21. Hepburn D, Divakar D, Bailey R et al. Cutaneous manifestations of renal transplantation in a New Zealand population. N Z Med J 1994; 107: 497-499
22. Bordea C, Wojnarowska F, Millard P et al. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004; 77: 574-579
23. Ramsay H, Fryer A, Reece S et al. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 2000; 36: 167-176
24. Ramsay H, Reece S, Fryer A et al. Seven-year prospective study of nonmelanoma skin cancer incidence in U.K. renal transplant recipients. Transplantation 2007; 84: 437-439
25. Harden P, Fryer A, Reece S et al. Annual incidence and predicted risk of nonmelanoma skin cancer in renal transplant recipients. Transplant Proc 2001; 33: 1302-1304
26. Glover M, Niranjan N, Kwan J et al. Non-melanoma skin cancer in renal transplant recipients: the extent of the problem and a strategy for management. Br J Plast Surg 1994; 47: 86-89
27. Tessari G, Barba A, Chieregato C et al. Risk factors for skin cancer in a group of renal transplant recipients. Acta Derm Venereol 1999; 79: 409-410
28. Comeau S, Jensen L, Cockfield SM et al. Non-melanoma skin cancer incidence and risk factors after kidney transplantation: a Canadian experience. Transplantation 2008; 86: 535-541
29. Marks R. Skin cancer in organ transplant patients: from a side effect of social practice to a side effect of medical practice. Dermatol Surg 2004; 30( Pt 2): 593-594
30. Sheil AG, Sheil AG. Patterns of malignancies following renal transplantation. Transplant Proc 1999; 31: 1263-1265
31. Bavinck J, De Boer A, Vermeer B et al. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993; 129: 242-249
32. Euvrard S, Kanitakis J, Pouteil-Noble C et al. Comparative epidemio-logic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Derma-tol 1995; 33(2 Pt 1): 222-229
33. Giles GG, Marks R, Foley P et al. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed) 1988; 296: 13-17
34. Kessler M, Jay N, Molle R et al. Excess risk of cancer in renal transplant patients. Transpl Int 2006; 19: 908-914
35. Barr BB, Benton EC, McLaren K et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1989; 1: 124-129
36. Marcén R, Pascuala J, Tatoa AM et al. Influence of immunosup-pression on the prevalence of cancer after kidney transplantation. Transplant Proc 2003; 35: 1714-1716
37. GuptaA,CardellaC, HabermanH. Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol 1986; 122: 1288-1293
38. Jemec G, Holm E. Nonmelanoma skin cancer in organ transplant patients. Transplantation 2003; 75: 253-257
39. Martinez J, Otley C, Stasko T et al. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003; 139: 301-306
40. Sheil A, Disney A, Mathew T et al. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc 1993; 25(1 Pt 2): 1383-1384
41. Burnworth B, Arendt S, Muffler S et al. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1. Eur J Cell Biol 2007; 86: 763-780
42. Buell J, Hanaway M, Thomas M et al. Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc 2005; 37: 962-963 (Pubitemid 40590760)
43. Fuente M, Sabat M, Roca J et al. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol 2003; 149: 1221-1226
44. Vogt P, Frei U, Repp H et al. Malignant tumours in renal transplant recipients receiving cyclosporin: survey of 598 first-kidney transplantations. Nephrol Dial Transplant 1990; 5: 282-288
45. Birkeland SA, Hamilton-Dutoit S. Is posttransplant lymphoprolifera-tive disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se? Transplantation 2003; 76: 984-988
46. Yarosh DB, Pena AV, Nay SL et al. Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation. J Invest Dermatol 2005; 125: 1020-1025
47. Penn I. Cancers in cyclosporine-treated vs azathioprine-treated patients. Transplant Proc 1996; 28: 876-878
48. Robson R, Cecka JM, Opelz G et al. Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil. Am J Transplant 2005; 5: 2954-2960
49. Dantal J, Pohanka E. Malignancies in renal transplantation: an unmet medical need. Nephrol Dial Transplant 2007; 22(suppl 1): i4-10
50. Boyle J, MacKie RM, Briggs JD et al. Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet 1984; 1: 702-705
51. Servilla KS, Burnham DK, Daynes RA. Ability of cyclosporine to promote the growth of transplanted ultraviolet radiation-induced tumors in mice. Transplantation 1987; 44: 291-295
52. Hojo M, Morimoto T, Maluccio M et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism.[see comment]. Nature 1999; 397: 530-534
53. Monaco AP, Monaco AP. The role of mtor inhibitors in the management of posttransplant malignancy. Transplantation 2009; 87: 157-163
54. Euvrard S, Kanitakis J, E D et al. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006; 81: 1093-1100